| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3972297
Max Phase: Preclinical
Molecular Formula: C26H26N6O
Molecular Weight: 438.54
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(Cn1nnc(-c2ccncc2)c1-c1ccccc1)Nc1ccc(N2CCCCC2)cc1
Standard InChI: InChI=1S/C26H26N6O/c33-24(28-22-9-11-23(12-10-22)31-17-5-2-6-18-31)19-32-26(21-7-3-1-4-8-21)25(29-30-32)20-13-15-27-16-14-20/h1,3-4,7-16H,2,5-6,17-19H2,(H,28,33)
Standard InChI Key: BCXZIOXUUGKUBX-UHFFFAOYSA-N
Associated Targets(non-human)
Probable protein-cysteine N-palmitoyltransferase porcupine 165 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 438.54 | Molecular Weight (Monoisotopic): 438.2168 | AlogP: 4.64 | #Rotatable Bonds: 6 |
| Polar Surface Area: 75.94 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 5.16 | CX LogP: 4.27 | CX LogD: 4.27 |
| Aromatic Rings: 4 | Heavy Atoms: 33 | QED Weighted: 0.47 | Np Likeness Score: -1.79 |
References
| 1. You L, Zhang C, Yarravarapu N, Morlock L, Wang X, Zhang L, Williams NS, Lum L, Chen C.. (2016) Development of a triazole class of highly potent Porcn inhibitors., 26 (24): [PMID:27876319] [10.1016/j.bmcl.2016.11.012] |
Source
Source(1):